
Strategic healthcare commercial leader with over 20 years in market access, portfolio growth, and commercialization across oncology, rare diseases, neuroscience, and specialty therapeutics. Led high-performing teams in launching complex products and forging strategic partnerships with IDNs, payers, and health systems. Committed to driving revenue growth and enhancing organizational impact within diverse healthcare landscapes.